Evidence map›Paper›PMID 35134559›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts.

Francisco Averhoff, Michael Berg, Mary Rodgers, Saladin Osmanov, Xinxin Luo, Mark Anderson, Todd Meyer, Alan Landay, Amiran Gamkrelidze, Esper G Kallas and 16 more

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The 2023 South Sudanese outbreak of Hepatitis E emphasizes ongoing circulation of genotype 1 in North, Central, and East Africa.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Francisco AverhoffAbbott Diagnostics, Abbott Park, IL, USA. Electronic address: francisco.averhoff@abbott.com.
Michael BergAbbott Diagnostics, Abbott Park, IL, USA. Electronic address: michael.berg@abbott.com.
Mary RodgersAbbott Diagnostics, Abbott Park, IL, USA.
Saladin OsmanovAbbott Diagnostics (deceased), Abbott Park, IL, USA.
Xinxin LuoAbbott Diagnostics, Abbott Park, IL, USA.
Mark AndersonAbbott Diagnostics, Abbott Park, IL, USA.
Todd MeyerAbbott Diagnostics, Abbott Park, IL, USA.
Alan LandayRush University Medical Center, Chicago, IL, USA.
Amiran GamkrelidzeNational Center for Disease Control, Tbilisi, Georgia.
Esper G KallasUniversity of Sao Paulo, Sao Paulo, Brazil.
Karl CiuoderisColombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia.
Juan Pablo HernandezColombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia.
Jean Hugues HenryQuisqueya University, Port-au-Prince, Haiti.
Jorge OsorioColombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia.
John LindoUniversity of the West Indies, Kingston, Jamaica.
Johnson DeshommesQuisqueya University, Port-au-Prince, Haiti.
Joshua AnzingerUniversity of the West Indies, Kingston, Jamaica.
Justen ManasaUniversity of Zimbabwe, Harare, Zimbabwe.
Maia AlkashviliNational Center for Disease Control, Tbilisi, Georgia.
Mboup SouleymanInstitute for Health Research, Epidemiologic Surveillance and Training (IRESSEF), Dakar, Senegal.
Pontiano KaleebuUganda Virus Research Institute, Entebbe, Uganda.
Rodrigo Correa-OliveiraFoundation Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Sunil SolomonJohns Hopkins University School of Medicine, USA & YRG CARE, Chennai, India.
Tulio de OliveraCentre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa.
Yupin SuputtamongkolMahidol University, Bangkok, Thailand.
Gavin ClohertyAbbott Diagnostics.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.

Indexed as

COVID-19PandemicsDisease OutbreaksHumansPublic HealthSARS-CoV-2emerging pathogens, virus discovery, surveillance, public healthPandemic preparedness

Identifiers

PMID35134559
PMCPMC8817457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.